Naringin, a grapefruit flavanone, protects V79 cells against the bleomycin-induced genotoxicity and decline in survival

Journal of Applied Toxicology

Volumn 27, Issue 2, 2007, Pages 122-132

  Jagetia, Abhinav ^a   Jagetia, Ganesh Chandra ^b   Jha, Shalini ^b  

^a MALAVIYA NATIONAL INSTITUTE OF TECHNOLOGY   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Bleomycin; Cell survival; Comet; DNA repair; Micronuclei; Naringin; V79 cells

Indexed keywords

AURANTIIN; BLEOMYCIN; FLAVONE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL PROTECTION; CELL STRAIN V 79; CELL SURVIVAL; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG ANTAGONISM; DRUG MECHANISM; GENOTOXICITY; GRAPEFRUIT; MICRONUCLEUS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIMUTAGENIC AGENTS; BLEOMYCIN; CELL LINE; CELL SURVIVAL; COMET ASSAY; CRICETINAE; DNA DAMAGE; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; FIBROBLASTS; FLAVANONES; LUNG; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MUTAGENS;

CITRUS X PARADISI;

EID: 33947575760     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1175     Document Type: Article

References (107)

1. Abend M, Rhein A, Gilbertz KP, Blakely WF, Van Beuningen D. 1995. Correlation of micronucleus and apoptosis assays with reproductive cell death. Int. J. Radiat. Biol. 67: 315-326.
2. Absalon MJ, Wu W, Kozarich JW, Stubbe J. 1995. Sequence-specific double-strand cleavage of DNA by Fe-bleomycin. 2. Mechanism and dynamics. Biochemistry 34: 2076-2086.
3. Adiga SK, Jagetia GC. 1999. Correlation between cell survival, micronuclei-induction, and LDH activity in V79 cells treated with teniposide (VM-26) before exposure to different doses of gamma radiation. Toxicol. Lett. 109: 31-41.
4. Ali MM, Kader MA. 2004. The influence of naringin on the oxidative state of rats with streptozotocin-induced acute hyperglycaemia. Z. Naturforsch. [C] 59: 726-733.
5. Alvarez-Gonzalez I, Madrigal-Bujaidar, Dorado V, Espinosa-Aguirre JJ. 2001. Inhibitory effect of naringin on the micronuclei induced by ifosfamide in mouse, and evaluation of its modulatory effect on the Cyp3a subfamily. Mutat. Res. 481: 171-178.
6. Babudri N, Pani B, Tamaro M, Monti-Bragadin C, Zunino F. 1984. Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells. Br. J. Cancer 50: 91-96.
7. Baichwal VR, Baeuerle PA. 1997. Activate NF-kappa B or die? Curr. Biol. 7: R94-R96.
8. Bauch T, Bocker W, Mallek U, Muller WU, Streffer C. 1999. Optimization and standardization of the 'comet assay' for analyzing the repair of DNA damage in cells. Strahlenther. Onkol. 175: 333-340.
9. Baumgartner A, Schmid TE, Cemeli E, Anderson D. 2004. Parallel evaluation of doxorubicin-induced genetic damage in human lymphocytes and sperm using the comet assay and spectral karyotyping. Mutagenesis 19: 313-318.
10. Bear WL, Teel RW. 2000. Effects of citrus flavonoids on the mutagenicity of heterocyclic amines and on cytochrome P450 1A2 activity. Anticancer Res. 20(5B): 3609-3614.
11. Blasiak J, Gloc E, Wozniak K, Mlynarski W, Stolarska M, Skorski T, Majsterek I. 2002. Genotoxicity of idarubicin and its modulation by vitamins C and E and amifostine. Chem. Biol. Interact. 140: 1-18.
12. Burger RM. 1998. Cleavage of nucleic acids by bleomycin. Chem. Rev. 98: 1153-1169.
13. Buschini A, Alessandrini C, Martino A, Pasini L, Rizzoli V, Carlo-Stella C, Poli P, Rossi C. 2002. Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cells. Biochem. Pharmacol. 63: 967-975.
14. Buschini A, Anceschi E, Carlo-Stella C, Regazzi E, Rizzoli V, Poli P, Rossi C. 2000. Amifostine (WR-2721) selective protection against melphalan genotoxicity. Leukemia 14: 1642-1651.
15. Bush C, McMillan TJ. 1993. Micronucleus formation in human tumor cells: lack of correlation with radiosensitivity. Br. J. Cancer 67: 102-106.
16. Caspary WJ, Niziak C, Lanzo DA, Friedman R, Bachur NR. 1979. Bleomycin A2: a ferrous oxidase. Mol. Pharmacol. 16: 256-260.
17. Cederberg H, Ramel C. 1989. Modifications of the effect of bleomycin in the somatic mutation and recombination test in Drosophila melanogaster. Mutat. Res. 214: 69-80.
18. Cemazar M, Miklavcic D, Sersa G. 1998. Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Jpn J. Cancer Res. 89: 328-333.
19. Chakraborty S, Roy M, Bhattacharya RK. 2004. Prevention and repair of DNA damage by selected phytochemicals as measured by single cell gel electrophoresis. J. Environ. Pathol. Toxicol. Oncol. 23: 215-226.
20. Champion AR, Hanson JA, Court JB, Venables SE. 1995. The micronucleus assay: an evaluation of its use in determining radiosensitivity in vitro. Mutagenesis 10: 203-208.
21. Charles K, Povirk LF. 1998. Action of bleomycin on structural mimics of intermediates in DNA double-strand cleavage. Chem. Res. Toxicol. 11: 1580-1585.
22. Chatterjee A, Jacob-Raman M. 1993. Protective effect of cysteine against x-ray and bleomycin-induced chromosomal aberrations and cell cycle delay. Mutat. Res. 290: 231-238.
23. Chen YT, Zheng RL, Jia ZJ, Ju Y. 1990. Flavonoids as superoxide scavengers and antioxidants. Free Radic. Biol. Med. 9: 19-21.
24. Collins A, Duthie S, Dobson V. 1993. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 14: 1733-1735.
25. Collins AR, Dobson VL, Dusinska M, Kennedy G, Stetina R. 1997. The comet assay: what can it really tell us? Mutat. Res. 375: 183-193.
26. Corticchiato M, Bernardini A, Costa J, Bayet C, Saunois A, Voirin B. 1995. Free flavonoid aglycones from Thymus herba barona and its monoterpenoid chemotypes. Phytochemistry 40: 115-120.
27. Delvaeye M, Verovski V, De Neve W, Storme G. 1993. DNA breakage, cytotoxicity, drug accumulation and retention in two human ovarian tumor cell lines AZ224 and AZ364 treated with adriamycin, modulated by verapamil. Anticancer Res. 13(5A): 1533-1538.
28. DuBois JL, Sneden AT. 1995. Dihydrolicoisoflavone, a new isoflavanone from Swartzia polyphylla. J. Nat. Prod. 58: 629-632.
29. Fairbairn DW, Olive PL, O'Neill KL. 1995. The comet assay: a comprehensive review. Mutat. Res. 339: 37-59.
30. Fenech M, Morley AA. 1985. Measurement of micronuclei in lymphocytes. Mutat. Res. 147: 29-36.
31. Glei M, Pool-Zobel BL. 2006. The main catechin of green tea, (-)-epigallocatechin-3-gallate (EGCG), reduces bleomycin-induced DNA damage in human leucocytes. Toxicol. In Vitro 20: 295-300.
32. Graciz WS. 1997. A bioactive naringenin coumaroyl glucoside from Mabea fistulifera subsp., Robusta. Planta Med. 63: 386.
33. Guo GZ, Sasai K, Oya N, Takagi T, Shibuya K, Hiraoka M. 1998. Simultaneous evaluation of radiation-induced apoptosis and micronuclei in five cell lines. Int. J. Radiat. Biol. 73: 297-302.
34. Hanuaske AR, Degen D, Hilsenbeck SG. 1992. Effects of taxotere and tax01 on in vitro colony formation of freshly explanted tumor cells. Anticancer Drugs 3: 121-124.
35. Harsch A, Marzilli LA, Bunt RC, Stubbe J, Vouros P. 2000. Accurate and rapid modeling of iron-bleomycin-induced DNA damage using tethered duplex oligonucleotides and electrospray ionization ion trap mass spectrometricanalysis. Nucleic Acid Res. 28: 1978-1985.
36. Hay J. Shahzeidi S, Laurent G. 1991. Mechanisms of bleomycin-induced lung damage. Arch. Toxicol. 65: 81-94.
37. Hecht SM. 1986. DNA strand scission by activated bleomycin group antibiotics. Fed. Proc. 45: 2784-2791.
38. Heddle JA, Hite M, Kirkhart B, Mavournin K, MacGregor JT, Newell GW, Salamone MF. 1983. The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res. 123: 61-118.
39. 0 human lymphocytes: I. Dose response and distribution. Environ. Mol. Mutagen. 21: 130-135.
40. Jagetia GC, Adiga SK. 1995. Influence of various concentrations of taxol on cell survival, micronuclei induction, and LDH activity in cultured V79 cells. Cancer Lett. 96: 195-200.
41. Jagetia GC, Adiga SK. 1997. Correlation between micronuclei induction and cell survival in V79 cells exposed to paclitaxel (taxol) in conjunction with radiation. Mutat. Res. 337: 105-113.
42. Jagetia GC, Adiga SK. 1998. Influence of vindescine on the micronucleus formation and cell survival in V79 cells. Mutat. Res. 421: 55-63.
43. Jagetia GC, Adiga SK. 2000. Correlation between cell survival and micronuclei formation in V79 cells treated with vindesine before exposure to different doses of gamma radiation. Mutat. Res. 448: 57-68.
44. Jagetia GC, Baliga SM. 2002. Vincristine increases the genomic instability in irradiated cultured human peripheral blood lymphocytes. Toxicol. Lett. 126: 179-186.
45. Jagetia GC, Ganapathi NG. 1994. Radiation-induced micronuclei formation in mouse bone marrow after low dose exposures. Mutat. Res. 304: 235-242.
46. Jagetia GC, Jacob PS. 1992. Vinblastine treatment induces dose-dependent increase in the frequency of micronuclei in mouse bone marrow. Mutat. Res. 280: 87-92.
47. Jagetia GC, Nayak V. 1996. Micronuclei-induction and its correlation to cell survival in HeLa cells treated with different doses of adriamycin. Cancer Lett. 110: 123-128.
48. Jagetia GC, Reddy TK. 2002. The grapefruit flavanone naringin protects against the radiation-induced genomic instability in the mice bone marrow: a micronucleus study. Mutat. Res. 519: 37-48.
49. Jagetia GC, Reddy TK. 2005. Modulation of radiation induced alteration in the antioxidant status of mice by naringin. Life Sci. 77: 780-794.
50. Jagetia GC, Reddy TK, Venkatesha VA, Kedlaya R. 2004. Influence of naringin on ferric iron induced oxidative damage in vitro. Clin. Chim. Acta 347: 189-197.
51. Jagetia GC, Venkatesha VA, Reddy TK. 2003. Naringin, a citrus flavonone, protects against radiation-induced chromosome damage in mouse bone marrow. Mutagenesis 18: 337-343.
52. Jaloszynski P, Kujawski M, Czub-Swierczek M, Markowska J, Szyfter K. 1997. Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay. Mutat. Res. 385: 223-233.
53. Jeon SM, Bok SH, Jang MK, Kim YH, Nam KT, Jeong TS, Park YB, Choi MS. 2002. Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits. Clin. Chim. Acta 317: 181-190.
54. Jeon SM, Bok SH, Jang MK, Lee MK, Nam KT, Park YB, Rhee SJ, Choi MS. 2001. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci. 69: 2855-2866.
55. Kane SA, Hecht SM. 1994. Polynucleotide recognition and degradation by bleomycin. Prog. Nucleic Acid Res. Mol. Biol. 49: 313-352.
56. Kawai K, Akaza H. 2003. Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer. Expert Opin. Drug Saf. 2: 587-596.
57. Kim DH, Bae EA, Han MJ. 1999. Anti-Helicobacter pylori activity of the metabolites of poncirin from Poncirus trifoliata by human intestinal bacteria. Biol. Pharm. Bull. 22: 422-424.
58. Kim HJ, Oh GT, Park YB, Lee MK, Seo HJ, Choi MS. 2004. Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed condition. Life Sci. 74: 1621-1634.
59. Konopacka M, Widel M, Rzeszowska-Wolny J. 1998. Modifying effect of vitamins C, E and beta-carotene against gamma-ray-induced DNA damage in mouse cells. Mutat. Res. 417: 85-94.
60. Kuhnau J. 1976. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet. 24: 117-191.
61. Kumar SS, Devasagayam TP, Jayashree B, Kesavan PC. 2001. Mechanism of protection against radiation-induced DNA damage in plasmid pBR322 by caffeine. Int. J. Radiat. Biol. 77: 617-623.
62. Kumaravel TS, Jha AN. 2006. Reliable Comet assay measurements for detecting DNA damage induced by ionising radiation and chemicals. Mutat. Res. 605: 7-16.
63. Kuo SM, Leavitt PS, Lin CP. 1998. Dietary flavonoids interact with trace metals and affect metallothionein level in human intestinal cells. Biol. Trace Elem. Res. 62: 135-153.
64. Labieniec M, Gabryelak T. 2005. Measurement of DNA damage and protein oxidation after the incubation of B14 Chinese hamster cells with chosen polyphenols. Toxicol. Lett. 155: 15-25.
65. Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN. 2000. Intake of flavonoids and lung cancer. J. Natl Cancer Inst. 92: 154-160.
66. Lee R, Kim YJ, Lee YJ, Chung HW. 2004. The selective effect of genistein on the toxicity of bleomycin in normal lymphocytes and HL-60 cells. Toxicology 195: 87-95.
67. Li MC, Hertz R, Spence DB. 1956. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc. Soc. Exp. Biol. Med. 93: 361.
68. Majer BJ, Laky B, Knasmuller S, Kassie F. 2001. Use of the micronucleus assay with exfoliated epithelial cells as a biomarker for monitoring individuals at elevated risk of genetic damage and in chemoprevention trials. Mutat. Res. 489: 147-172.
69. Malyapa RS, Bi C, Ahern EW, Roti Roti JL. 1998. Detection of DNA damage by the alkaline comet assay after exposure to low-dose gamma radiation. Radiat. Res. 149: 396-400.
70. Mariya Y, Streffer C, Fuhrmann C, Wojcik A. 1997. Correlation of radiation-induced micronucleus frequency with clonogenic survival in cells of one diploid and two tetraploid murine tumor cell lines of the same origin. Radiat. Res. 147: 29-34.
71. Maurya DK, Salvi VP, Nair CK. 2005. Radiation protection of DNA by ferulic acid under in vitro and in vivo conditions. Mol. Cell Biochem. 280: 209-217.
72. Midander J, Revesz L. 1980. The frequency of micronuclei as a measure of cell survival in irradiated cell populations. Int. J. Radiat. Biol. 38: 237-242.
73. Mira L, Fernandez MT, Santos M, Rocha R, Florencio MH, Jennings KR. 2002. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic. Res. 36: 1199-1208.
74. Nagy B, Grdina DJ. 1986. Protective effects of 2-[(aminopropyl)amino] ethanethiol against bleomycin and nitrogen mustard-induced mutagenicity in V79 cells. Int. J. Radiat. Oncol. Biol. Phys. 12: 1475-1478.
75. Olive PL. 1999. DNA damage and repair in individual cells: applications of the comet assay in radiobiology. Int. J. Radiat. Biol. 75: 395-405.
76. Olive PL, Durand RE. 1992. Detection of hypoxic cells in a murine tumor with the use of the comet assay. J. Natl Cancer Inst. 84: 707-711.
77. Ortiz LA, Champion HC, Lasky JA, Gambelli F, Goza E, Hoyle GW, Beasley MB, Hyman AL, Friedman M, Kadowitz PJ. 2002. Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-B and AP-1. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L1209-L1221.
78. Pedersen-Bjergaard J, Rowley JD. 1994. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83: 2780-2786.
79. Perkins ND. 2000. The Rel/NF-kappa B family: friend and foe. Trends Biochem. Sci. 25: 434-440.
80. Povirk LF, Austin MJ. 1991. Genotoxicity of bleomycin. Mutat. Res. 257: 127-143.
81. Povirk LF, Houlgrave CW. 1988. Effect of apurinic/apyrimidinic endonucleases and polyamines on DNA treated with bleomycin and neocarzinostatin: specific formation and cleavage of closely opposed lesions in complementary strands. Biochemistry 27: 3850-3857.
82. Price ME, McKelvey-Martin VJ, Robson T, Hirst DG, McKeown SR. 2000. Induction and rejoining of DNA double-strand breaks in bladder tumor cells. Radiat. Res. 153: 788-794.
83. Puck TT, Marcus PI. 1955. A rapid method for viable cell titration and clone production with HeLa cells in tissue culture. The use of x-irradiated cells to supply conditioning factors. Proc. Natl Acad. Sci. USA 41: 432-437.
84. Rownisky EK, Donehower RC, Jones RJ, Tucker RW. 1988. Microtubule changes and cytotoxicity in leukaemic cell lines treated with taxol. Cancer Res. 48: 4093-4100.
85. Russo A, Acquaviva R, Campisi A, Sorrenti V, Di Giacomo C, Virgata G, Barcellona ML, Vanella A. 2000. Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors. Cell Biol. Toxicol. 16: 91-98.
86. Sam JW, Peisach J. 1993. EPR spectroscopic investigation of the lability of oxygen in activated bleomycin: implications for the mechanism of bleomycin-mediated DNA degradation. Biochemistry 32: 1488-1491.
87. Schwarz D, Kisselev P, Roots I. 2005. CYP1A1 genotype-selective inhibition of benzo[a]pyrene activation by quercetin. Eur. J. Cancer 4: 1151-1158.
88. Serrano-Mollar A, Closa D, Prats N, Blesa S, Martinez-Losa M, Cortijo J, Estrela JM, Morcillo EJ, Bulbena O. 2003. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br. J. Pharmacol. 138: 1037-1048.
89. Singh D, Chander V, Chopra K. 2004. Protective effect of naringin, a bioflavonoid on ferric nitrilotriacetate-induced oxidative renal damage in rat kidney. Toxicology 201: 1-8.
90. Singh D, Chopra K. 2004. The effect of naringin, a bioflavonoid on ischemia-reperfusion induced renal injury in rats. Pharmacol. Res. 50: 187-193.
91. Singh NP, McCoy MT, Tice RR, Schneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175: 184-191.
92. Smith BL, Bauer GB, Povirk LF. 1994. DNA damage induced by bleomycin, neocarzinostatin, and melphalan in a precisely positioned nucleosome. Asymmetry in protection at the periphery of nucleosome-bound DNA. J. Biol. Chem. 269: 30587-30594.
93. Sognier MA, Eberle RL, Zhang Y, Belli JA. 1991. Interaction between radiation and drug damage in mammalian cells. V. DNA damage and repair induced in LZ cells by adriamycin and/or radiation. Radiat. Res. 126: 80-87.
94. Stap J, Aten JA. 1990. Comparison of radiation sensitivity for three cell lines as measured by the cloning assay and the micronucleus test. Strahlenther. Onkol. 166: 761-763.
95. Steighner RJ, Povirk LF. 1990. Bleomycin-induced DNA lesions at mutational hot spots: implications for the mechanism of double-strand cleavage. Proc. Natl Acad. Sci. USA 87: 8350-8354.
96. Stubbe J, Kozarich JW, Wu W, Vanderwall DE. 1996. Bleomycins: A structural model for specificity, binding, and double strand cleavage. Acc. Chem. Res. 29: 322-330.
97. Swiader KE, Zarawska E. 1996. Flavonoids of rare artemisia species and their antifungal properties. Fitoterapia 67: 77-78.
98. Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF. 1984. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226: 466-468.
99. Ueng YF, Chang YL, Oda Y, Park SS, Liao JF, Lin MF, Chen CF. 1999. In vitro and in vivo effects of naringin on cytochrome P450-dependent monooxygenase in mouse liver. Life Sci. 65: 2591-2602.
100. Umezawa H. 1965. Bleomycin and other antitumor antibiotics of high molecular weight. Antimicrobial Agents Chemother. (Bethesda) 5: 1079-1085.
101. Umezawa H, Maeda K, Takeuchi T, Okami Y. 1966. New antibiotics, bleomycin A and B. J. Antibiot. (Tokyo) 19: 200-209.
102. Vig BK, Lewis R. 1978. Genetic toxicology of bleomycin. Mutat. Res. 55: 121-145.
103. Wallach-Dayan SB, Izbicki G, Cohen PY, Gerstl-Golan R, Fine A, Breuer R. 2006. Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L790-L796.
104. Wilcox L, Borradaile M, Murray WH. 1999. Antiatherogenic properties of naringenin, a citrus flavonoid. Cardiovasc. Drug Rev. 2: 160-178.
105. Wozniak K, Arabski M, Malecka-Panas E, Drzewoski J, Blasiak J. 2004. DNA damage in human colonic mucosa cells induced by bleomycin and the protective action of vitamin E. Cell Mol. Biol. Lett. 9: 31-45.
106. Yamauchi T, Keating MJ, Plunkett W. 2002. UCN-01 (7-hydroxystaurosporine) inhibits DNA repair and increases cytotoxicity in normal lymphocytes and chronic lymphocytic leukemia lymphocytes. Mol. Cancer Ther. 1: 287-294..
107. Yeh SL, Wang WY, Huang CH, Hu ML. 2005. Pro-oxidative effect of beta-carotene and the interaction with flavonoids on UVA-induced DNA strand breaks in mouse fibroblast C3H10T1/2 cells. J. Nutr. Biochem. 16: 729-735.